Literature DB >> 2858423

Prolonged hyperglycaemia during infusion of glucose and somatostatin impairs pancreatic A- and B-cell responses to decrements in plasma glucose in normal man: evidence for induction of altered sensitivity to glucose.

G Dimitriadis, P Cryer, J Gerich.   

Abstract

To determine the effects of prolonged hyperglycaemia on pancreatic islet A- and B-cell function, plasma glucose was clamped for 12 h at approximately 11 and 5 mmol/l in control experiments by infusing glucose and somatostatin along with replacement amounts of insulin, glucagon, and growth hormone in seven normal volunteers. Following restitution of euglycaemia for 1 h after prolonged hyperglycaemia, termination of the somatostatin-replacement hormone infusions resulted in a sustained decrease in plasma glucose to 3 mmol/l (p less than 0.01). Despite this, plasma glucagon did not increase above values observed in control experiments in which plasma glucose did not decrease; moreover, there was a persistent increase in insulin secretion nearly threefold above that observed in control experiments (p less than 0.01). Plasma growth hormone, cortisol and adrenaline responses were appropriate. This failure of a decrement in plasma glucose to suppress insulin secretion and to stimulate glucagon secretion was not observed when comparable hypoglycaemia was induced by exogenous insulin after a prolonged euglycaemic clamp. Our results indicate that hyperglycaemia can induce altered sensitivity of pancreatic A and B cells to glucose and suggest that abnormal A- and B-cell responses to glucose in diabetes mellitus may not represent a wholly intrinsic defect.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858423     DOI: 10.1007/bf00279917

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  35 in total

1.  Prolonged suppression of insulin release by insulin-induced hypoglycemia: demonstration by C-peptide assay.

Authors:  D L Horwitz; A H Rubenstein; C Reynolds; G D Molnar; N Yanaihara
Journal:  Horm Metab Res       Date:  1975-11       Impact factor: 2.936

2.  Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects. A glucose dose-response study.

Authors:  E Cerasi; R Luft; S Efendic
Journal:  Diabetes       Date:  1972-04       Impact factor: 9.461

3.  Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus.

Authors:  P J Savage; L J Bennion; E V Flock; M Nagulesparan; D Mott; J Roth; R H Unger; P H Bennett
Journal:  J Clin Endocrinol Metab       Date:  1979-06       Impact factor: 5.958

4.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

5.  Effect of control of blood glucose on plasma insulin responses to various stimuli in secondary failures to oral hypoglycemic agents and in newly diagnosed, maturity onset, ketosis-resistant diabetics.

Authors:  R Schmeltz; H J Wendorff; J B Field
Journal:  J Clin Endocrinol Metab       Date:  1978-04       Impact factor: 5.958

6.  The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemia.

Authors:  P Vague; J P Moulin
Journal:  Metabolism       Date:  1982-02       Impact factor: 8.694

7.  Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.

Authors:  J P Palmer; J W Benson; R M Walter; J W Ensinck
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

8.  The effect of treatment of type 2 (insulin independent) diabetes mellitus on plasma concentrations of pancreatic polypeptide and glucagon.

Authors:  D Berger; J C Floyd; S B Pek
Journal:  Diabetologia       Date:  1981-08       Impact factor: 10.122

9.  Glucose clamping using the Biostator GCIIS.

Authors:  C A Verdonk; R A Rizza; R E Westland; R L Nelson; J E Gerich; F J Service
Journal:  Horm Metab Res       Date:  1980-04       Impact factor: 2.936

10.  Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior.

Authors:  R P Eaton; R C Allen; D S Schade; K M Erickson; J Standefer
Journal:  J Clin Endocrinol Metab       Date:  1980-09       Impact factor: 5.958

View more
  6 in total

1.  Diet only or diet and sulfonylureas in mild type II diabetes (NIDDM)? Pathophysiologic and therapeutic implications.

Authors:  I R Sinay; P Arias; M A Schnitman; S A Damilano; M C Faingold; J A Moguilevsky
Journal:  Acta Diabetol Lat       Date:  1988 Oct-Dec

2.  Hyperinsulinemia in glucose intolerance: is it true?

Authors:  D Giugliano; A Quatraro; R Acampora; N De Rosa; A Ceriello; F D'Onofrio
Journal:  J Endocrinol Invest       Date:  1994-06       Impact factor: 4.256

3.  The alpha cell response to glucose change during perfusion of anti-insulin serum in pancreas isolated from normal rats.

Authors:  H Maruyama; M Tominaga; G Bolli; L Orci; R H Unger
Journal:  Diabetologia       Date:  1985-11       Impact factor: 10.122

4.  No glucotoxicity after 53 hours of 6.0 mmol/l hyperglycaemia in normal man.

Authors:  H Flax; D R Matthews; J C Levy; S W Coppack; R C Turner
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

5.  Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions.

Authors:  J L Leahy; H E Cooper; D A Deal; G C Weir
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

6.  Quantitative measurement of islet glucagon response to hypoglycemia by confocal fluorescence imaging in diabetic rats: effects of phlorizin treatment.

Authors:  K S Rastogi; R L Cooper; Z Q Shi; M Vranic
Journal:  Endocrine       Date:  1997-12       Impact factor: 3.633

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.